Researchers at Johns Hopkins Medicine have discovered a potential method to enhance the effectiveness of mRNA therapies by utilizing a natural RNA modification called N4-acetylcytidine (ac4C). This modification allows cells to produce more therapeutic proteins compared to the current standard, potentially leading to more efficient drugs with smaller doses. If validated in further studies, this finding could significantly impact the development of vaccines and treatments for various diseases.